Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
KASINGER JAMES R.
General Counsel and Secretary at CRISPR Therapeutics. Filing since 19 Jan 2021.
CIK 0001708172
Company
Date
Role
Action
Shares
Amount
Of holding
CRSP
CRISPR Therapeutics AG
6 Oct 2026
General Counsel and Secretary
Sold on a plan
1,990
$119.48K
2.1%
CRSP
CRISPR Therapeutics AG
22 Sep 2026
General Counsel and Secretary
Sold on a plan
10,400
$626.46K
9.9%
CRSP
CRISPR Therapeutics AG
23 Mar 2026
General Counsel and Secretary
Sold at will
3,182
$148.85K
3.3%
CRSP
CRISPR Therapeutics AG
16 Mar 2026
General Counsel and Secretary
Sold at will
3,450
$166.50K
3.6%
CRSP
CRISPR Therapeutics AG
11 Mar 2026
General Counsel and Secretary
Sold at will
2,800
$147.84K
3.1%
CRSP
CRISPR Therapeutics AG
19 Feb 2026
General Counsel and Secretary
Sold at will
2,112
$111.05K
2.4%
CRSP
CRISPR Therapeutics AG
14 Oct 2025
General Counsel and Secretary
Sold at will
1,076
$71.66K
1.3%
CRSP
CRISPR Therapeutics AG
21 Mar 2025
General Counsel and Secretary
Sold at will
3,185
$131.32K
3.8%
CRSP
CRISPR Therapeutics AG
12 Mar 2025
General Counsel and Secretary
Sold at will
1,116
$48.35K
1.4%
CRSP
CRISPR Therapeutics AG
11 Mar 2025
General Counsel and Secretary
Sold at will
2,850
$120.90K
3.5%
CRSP
CRISPR Therapeutics AG
19 Feb 2025
General Counsel and Secretary
Sold at will
1,947
$102.80K
2.5%
CRSP
CRISPR Therapeutics AG
18 Feb 2025
General Counsel and Secretary
Sold at will
9,595
$516.69K
11.6%
CRSP
CRISPR Therapeutics AG
14 Oct 2024
General Counsel and Secretary
Sold at will
1,089
$50.40K
1.7%
CRSP
CRISPR Therapeutics AG
12 Mar 2024
General Counsel and Secretary
Sold at will
1,146
$85.31K
1.8%
CRSP
CRISPR Therapeutics AG
11 Mar 2024
General Counsel and Secretary
Sold at will
2,801
$219.21K
4.5%
CRSP
CRISPR Therapeutics AG
20 Feb 2024
General Counsel and Secretary
Sold at will
1,913
$152.41K
3.2%
CRSP
CRISPR Therapeutics AG
19 Jan 2021
General Counsel and Secretary
Sold, plan not stated
27,500
$5.64M
55.1%
17 decisions on file.
